Real-time continuous glucose monitoring in randomized control trials.

Abstract

Several recent randomized controlled trials offer firm evidence supporting the efficacy and safety of real-time continuous glucose monitoring (RT-CGM) in type 1 diabetes mellitus (T1DM). Improved metabolic control with significant lowering of glycated hemoglobin (A1C) along with other parameters of glycemia, and without a concomitant increase in hypoglycemia, has been demonstrated. However, poor compliance in adolescents has been a limiting factor in that age group. The potential of RT-CGM of reducing hypoglycemia in well-controlled individuals with T1DM is anticipated but remains to be confirmed. The current high cost of this technology may limit clinical experience in routine clinical settings.

• Authors: Tadej Battelino, Moshe Phillip
• Journal: Pediatric endocrinology reviews : PER (Pediatr Endocrinol Rev) Vol. 7 Suppl 3 Pg. 401-4 (Aug 2010) ISSN: 1565-4753 [Print] Israel
• PMID: 20877253 (Publication Type: Journal Article, Review)

Chemical References

• Blood Glucose
• Glycated Hemoglobin A
• Insulin

Topics

• Adolescent
• Adult
• Blood Glucose (analysis)
• Child
• Diabetes Mellitus, Type 1 (blood, drug therapy)
• Glycated Hemoglobin (analysis)
• Humans
• Insulin (administration & dosage)
• Insulin Infusion Systems
• Monitoring, Ambulatory (methods)
• Randomized Controlled Trials as Topic (methods)
• Young Adult